Huntington's disease (HD) is a progressive neurodegenerative disorder that impacts a person's physical, mental, and cognitive abilities. 

Treatment of Chorea in Huntington's Disease

Huntington's disease (HD) is a progressive neurodegenerative disorder that impacts a person's physical, mental, and cognitive abilities. One of its most distinctive and often distressing symptoms is chorea, characterized by involuntary, irregular, unpredictable, rapid, jerky movements. While there is currently no cure for Huntington's disease, managing chorea is a crucial aspect of improving the quality of life for individuals living with the condition.

Understanding Chorea in Huntington's Disease

Chorea arises from the degeneration of specific neurons in the brain, particularly in the basal ganglia, which play a vital role in motor control. These involuntary movements can affect any part of the body, including the face, trunk, and limbs. They can range from mild fidgeting to severe, disabling movements that interfere with walking, eating, speaking, and daily activities, increasing the risk of falls and injuries.

Effective management of chorea aims to reduce the frequency and severity of these movements, thereby enhancing functional independence, reducing discomfort, and improving overall well-being. Treatment strategies often involve a combination of pharmacological interventions and supportive therapies tailored to the individual's specific needs.

Pharmacological Treatment Options for Chorea

Medications are a primary approach to reduce the severity of chorea. The goal is symptom reduction, not a cure, and treatment plans are often adjusted over time as the disease progresses.

FDA-Approved Medications

Several medications have been specifically approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington's disease:

• Tetrabenazine (Xenazine): This was the first FDA-approved drug for HD-related chorea. It works by depleting dopamine and other monoamines from nerve endings in the brain, which helps to reduce involuntary movements. Common side effects can include sedation, insomnia, depression, and parkinsonism.


• Deutetrabenazine (Austedo): A newer medication, deutetrabenazine is a deuterated form of tetrabenazine. Deuteration modifies the drug's metabolism, allowing for a longer half-life and potentially fewer side effects, such as sedation, compared to tetrabenazine. It also works by reducing dopamine levels.


• Valbenazine (Ingrezza): Approved more recently, valbenazine is another vesicular monoamine transporter 2 (VMAT2) inhibitor, similar to tetrabenazine and deutetrabenazine. It provides another option for managing chorea, with its own profile of efficacy and potential side effects, which may include somnolence and QT prolongation.

Off-Label and Supportive Medications

In some cases, other medications may be used off-label to help manage chorea or its associated symptoms, though their use is generally considered when FDA-approved options are not suitable or sufficient:

• Antipsychotics: Medications like haloperidol, risperidone, or olanzapine may be used to suppress chorea, particularly in severe cases. However, they can have significant side effects, including sedation, weight gain, and an increased risk of parkinsonism.


• Benzodiazepines: Drugs such as clonazepam can help reduce chorea severity and address other symptoms like anxiety or sleep disturbances, but they carry risks of sedation and dependency.

Non-Pharmacological Strategies and Supportive Care

A holistic approach to managing chorea in Huntington's disease extends beyond medication. Non-pharmacological interventions are vital for maintaining function and improving overall quality of life.

Physical Therapy

Physical therapists can develop exercise programs to improve balance, coordination, strength, and flexibility, which can help manage chorea's impact on movement and reduce the risk of falls. They may also suggest adaptive techniques for walking and daily activities.

Occupational Therapy

Occupational therapists focus on enabling individuals to perform daily tasks more easily. This can involve recommending assistive devices (e.g., weighted utensils, specialized cups), modifying the home environment to enhance safety and accessibility, and teaching compensatory strategies for tasks affected by involuntary movements.

Speech Therapy

Chorea can affect the muscles involved in speech (dysarthria) and swallowing (dysphagia). Speech therapists can help with exercises to improve articulation, vocal control, and swallowing safety. They can also recommend communication aids or strategies for clearer communication.

Nutritional Support

The constant involuntary movements of chorea increase caloric expenditure, making weight loss a common concern. Nutritional guidance from a dietitian can help ensure adequate caloric intake and recommend easier-to-eat foods to maintain weight and energy levels.

Psychosocial Support

Living with Huntington's disease and chorea can be emotionally challenging. Psychosocial support, including counseling, support groups, and cognitive behavioral therapy, can help individuals and their families cope with the psychological and emotional impact of the disease.

The Importance of a Multidisciplinary Approach

Effective treatment for chorea in Huntington's disease typically requires a multidisciplinary team. This team may include neurologists, psychiatrists, physical therapists, occupational therapists, speech therapists, social workers, and dietitians. Collaborating ensures that all aspects of the disease, including motor, cognitive, and psychiatric symptoms, are addressed in a comprehensive and individualized treatment plan.

Managing chorea is a continuous process that involves careful monitoring, adjusting medications, and adapting supportive therapies as the disease progresses. The ultimate goal is to minimize the impact of chorea, enhance safety, and preserve the highest possible level of independence and dignity for individuals with Huntington's disease.

Individuals experiencing chorea related to Huntington's disease should consult with a neurologist or a specialized HD clinic to receive an accurate diagnosis and develop a personalized treatment strategy.